All Stories

  1. Securing the chest tube: in search of the elusive solution
  2. Management of recurrent transudative pleural effusions: can we REDUCE unnecessary interventions?
  3. Ambulatory management of secondary spontaneous pneumothorax: a mirage, or a solution on the horizon?
  4. PILOTing towards a RAPID predictor of mortality for infectious pleural effusions
  5. Pleural diseases and COVID-19: ubi fumus, ibi ignis
  6. PLEASE, take a deep breath
  7. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial
  8. Dual intracavitary therapy for pleural infections: leaving reluctance behind
  9. Ultrasound-based elastography: “hard” to implement in the pleural effusion work-up?
  10. Improving the management of spontaneous pneumothorax
  11. Phenotyping primary spontaneous pneumothorax
  12. Biomarkers in the diagnosis of pleural diseases: a 2018 update
  13. Computed tomography scoring system for discriminating between parapneumonic effusions eventually drained and those cured only with antibiotics
  14. Comparing approaches to the management of malignant pleural effusions
  15. Trends in Pleural Effusion Research: A Bibliometric Analysis From the Scopus Database
  16. Comparison of pleural N‐terminal pro‐B‐type natriuretic peptide, midregion pro‐atrial natriuretic peptide and mid‐region pro‐adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure